The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tocilizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 356     Number of Pages: 18

DRUGNAME PT EventCount
Tocilizumab Influenza like illness 1 view events
Tocilizumab Intervertebral disc protrusion 1 view events
TOCILIZUMAB Intestinal perforation 1 view events
Tocilizumab Intestinal resection 1 view events
Tocilizumab Invasive ductal breast carcinoma 1 view events
TOCILIZUMAB Joint swelling 1 view events
Tocilizumab Knee arthroplasty 1 view events
Tocilizumab Limb injury 1 view events
Tocilizumab Limb operation 1 view events
Tocilizumab Lipoma 1 view events
TOCILIZUMAB Live birth 1 view events
Tocilizumab Liver function test abnormal 1 view events
TOCILIZUMAB Liver function test increased 1 view events
Tocilizumab Lower limb fracture 1 view events
Tocilizumab Lupus-like syndrome 1 view events
TOCILIZUMAB Lymphadenopathy 1 view events
Tocilizumab Lymphocyte count increased 1 view events
Tocilizumab Lymphopenia 1 view events
TOCILIZUMAB Lymphoproliferative disorder 1 view events
TOCILIZUMAB Malignant melanoma 1 view events

Total Drug/Injury Combinations: 356     Number of Pages: 18

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)